INTRODUCTION
Bacterial spores are dormant cells, are extremely resistant to harsh environmental conditions and are able to survive indefinitely in the absence of water and nutrients (Nicholson et al., 2000) . Bacillus subtilis is the most characterized species of bacterial spore formers, and a variety of genetic tools are available to make feasible its manipulation. B. subtilis is a non-pathogenic species and is considered as GRAS (generally regarded as safe) by the US Food and Drug Administration. In addition, B. subtilis has an uncontested safety record based on the worldwide commercial use of its spores as probiotics for humans and animals and for the oral prophylaxis of gastrointestinal disorders.
Spore coat assembly involves the deposition of at least 50 protein species (Henriques & Moran, 2007; Kuwana et al., 2002; Lai et al., 2003) into two major layers: an electrondense outer layer called the outer coat and a less-electrondense inner layer with a lamellar appearance, called the inner coat (Warth et al., 1963) . A loose-fitting, balloon-like exosporium surrounds the spore coats of some species, including Bacillus anthracis, Bacillus cereus and some clostridia. This structure is not observed in the B. subtilis spore. Therefore, the outermost layer of the B. subtilis spore is thought to be the structure termed the crust (McKenney et al., 2010) . The crust consists of a number of proteins including three morphogenetic proteins, CotX, CotY and CotZ (Imamura et al. 2011; McKenney et al. 2010; Zhang et al. 1993) .
In terms of its stability, safety properties and the selfassembled structure that surrounds it, the spore is an ideal 'live' nanobiotechnological tool with a number of potential applications that include self-assembly and display and delivery of heterologous proteins (Barák et al., 2005; . In previous studies, heterologous proteins have been efficiently exposed on the B. subtilis spore surface (Hinc et al., 2010; Isticato et al., 2001 Isticato et al., , 2007 Mauriello et al., 2004; Tavasoli et al., 2013) . In these studies, chimaeras, formed by a structural component of the spore coat and a heterologous part, were obtained by constructing gene fusions between DNA coding for a spore coat gene and heterologous DNA. Recombinant proteins are synthesized in sporulating cells and then assembled on the surface of the forming spore as spore coat components. This approach allowed the display of bacterial and viral antigens on the spore surface and led to the proposal of the recombinant spore as a new oral vaccine vehicle (Duc et al., 2003; Mauriello et al., 2007; Permpoonpattana et al., 2011) .
CotZ, to display of a fragment of FliD, the flagellar cap protein of Clostridium difficille flagellin. Two C. difficile flagellar proteins, FliC, the flagellin structural monomer, and FliD, have been reported to be involved in the attachment of the organism to host cells and the intestinal mucus layer (Tasteyre et al., 2001) . Moreover, studies of recuperating C. difficile infection patients have shown that serum antibody responses against both FliC and FliD are generated, implicating them as important virulence factors during the course of C. difficile infection (Péchiné et al., 2005) . These data suggest that such recombinant spores could serve as an oral vaccine against C. difficile infection.
METHODS
Bacterial strains and transformation. The B. subtilis strains used in this study are listed in Table 1 . Plasmid amplifications for nucleotide sequencing and subcloning experiments were performed with Escherichia coli strain DH5a (Sambrook et al., 1989) . Bacterial strains were transformed using previously described procedures for CaCl 2 -mediated transformation of E. coli competent cells (Sambrook et al., 1989) and transformation of B. subtilis (Julkowska et al., 2005) .
Construction of gene fusions. To obtain the various gene fusions, DNA coding for the selected coat protein was PCR amplified using the B. subtilis chromosome as a template and the primer pairs cotB-F/ cotB-R, cotC-F/cotC-R, cotG-F/cotG-R and cotZ-F/cotZ-R (Table 2) for fusions cotB-fliD, cotC-fliD, cotG-fliD and cotZ-fliD, respectively. Amplification products of 1094 bp (cotB-fliD), 383 bp (cotC-fliD), 1031 bp (cotG-fliD) and 1256 bp (cotZ-fliD) were obtained and cloned into the pDL vector (Yuan & Wong, 1995) obtained from Bacillus Genetic Stock Center, yielding plasmids pDL-CotB, pDLCotC, pDL-CotG and pDL-CotZ, respectively.
A 280 bp DNA fragment coding for a fragment of FliD was PCR amplified using C. difficile strain 630 chromosome as template and primers fliD-F and fliD-R ( Table 2 ). The PCR product was sequentially digested with BamHI and SacI and cloned in frame to the 39 end of the cotB, cotC, cotG and cotZ genes carried by plasmids pDL-CotB, pDL-CotC, pDL-CotG and pDL-CotZ, yielding plasmids pAN01, pAN02, pAN03 and pAN04, respectively. In the case of the CotB-GGGEAAAKGGG-UreA fusion, primers linker-gggeaaakggg-F and linker-gggeaaakggg-R were used (Table 2) yielding plasmid pAN05.
Chromosomal integration. Appropriate plasmids were linearized by digestion with a single-cutting restriction enzyme. Linearized DNA was used to transform competent cells of B. subtilis strain 168. Chloramphenicol-resistant clones were the result of a doublecrossover recombination event, resulting in the interruption of the non-essential amyE gene on the B. subtilis chromosome. Several chloramphenicol-resistant clones were tested by PCR using chromosomal DNA as template and primers AmyS and AmyA (Isticato et al., 2004) . The selected clones were named BAN01, BAN02, BAN03, BAN04 and BKH05 and kept for further studies.
Preparation of spores. Sporulation was induced by the exhaustion method in Difco sporulation medium (DSM) as described elsewhere (Nicholson & Setlow, 1990) . Sporulating cultures were harvested 24 h after the initiation of sporulation and purified using a lysozyme treatment to break up any residual sporangial cells, followed by washing steps in 1 M NaCl, 1 M KCl and water (twice each), as described by Nicholson & Setlow (1990) . PMSF (0.05 M) was included to inhibit proteolysis. After the final suspension in water, spores were treated at 65 uC for 1 h to kill any residual cells. The spore suspension was titrated immediately for determination of c.f.u. ml 21 before freezing at 220 uC. Using this method, we could reliably produce 6610 10 spores in 1 litre of DSM culture.
Extraction of spore coat proteins. Spore coat proteins were extracted from 50 ml of a suspension of spores at high density (1610 10 spores ml 21 ) using a decoating extraction buffer as described elsewhere (Monroe & Setlow, 2006) . Extracted proteins were assessed for integrity by SDS-PAGE and for concentration by two independent methods: a BCA Protein Assay (Pierce) and a DC Protein Assay kit (Bio-Rad).
Western and dot blot analyses. Extracted proteins were separated in 12 % denaturing polyacrylamide gels, electrotransferred onto a nitrocellulose filter (Roti-NC; ROTH) and used for Western blotting by standard procedures. Western blot filters were visualized by developing with BCIP/NBT according to the manufacturer's instructions (Fermentas). Serial dilutions of extracted proteins and purified FliD were used for dot blot analysis. Filters were then visualized by incubation with BCIP/NBT as above, followed by densitometric analysis with Chemidoc XRS (Bio-Rad) and MultiAnalyst software.
Immunofluorescence microscopy. Samples were fixed directly in the medium as described by Harry et al. (1995) , with the following modifications: spores were suspended in TE buffer [20 mM Tris/HCl (pH 7.5), 10 mM EDTA] containing 2 mg lysozyme ml 21 . After 3 min of incubation, three washes in PBS (pH 7.4) were performed before blocking with 3 % skimmed milk in PBS for 30 min at room temperature and washing another three times in PBS. Samples were incubated overnight at 4 uC with mouse anti-fliD antibody, washed three times and then incubated with anti-mouse Cy3-conjugated IgG (Jackson ImmunoResearch Laboratories) overnight at 4 uC. After three washes with PBS, samples were loaded on microscope slides previously coated with poly-L-lysine (Sigma). The coverslips were mounted on a microscope slide and viewed using a Zeiss Axioplan fluorescence microscope with the same exposure time for all samples. Images were captured using a camera connected to the microscope, processed with Corel Photo-Paint software and saved in TIFF format.
Purification of FliD and antibody production. The fliD gene of C. difficile was PCR amplified using chromosomal DNA as template and primers FD-F and FD-R ( Table 2 ). The obtained PCR product of 1544 bp was digested with BamHI and KpnI and cloned into the commercial vector pRSET A (Life Technologies). The resulting plasmid, pKH126, was verified by restriction analysis and nucleotide sequencing. pKH126 was used to transform E. coli strain BL21, and the recombinant strain was used to overproduce FliD by induction with 1 mM IPTG. A 60 kDa protein was visualized on a Coomassieblue stained gel and purified on Ni-NTA Superflow Agarose (Qiagen). One milligram of pure FliD protein was obtained from 3 l of culture. For antibody production, six C57BL/6J mice were immunized intraperitoneally with 30 mg purified FliD per mouse with incomplete Freund's adjuvant in a total volume of 300 ml. The injections took place on days 0, 14, 35 and 56. On days 24 and 45, serum samples were taken by tail bleeding. On day 66, total blood was collected. The obtained sera were tested against purified protein and the optimal dilution of anti-FliD sera was established as 1 : 100 000 for Western blot analysis.
RESULTS

Construction and chromosomal integration of gene fusions
To obtain recombinant B. subtilis spores expressing FliD on their surface, we used four Cot proteins, CotB, CotC, CotG and CotZ, as carriers. To achieve this, the coding part of the fliD gene of C. difficile was fused in frame with the coding part of cotB, cotC, cotG or cotZ as specified below. All gene fusions retained the promoter of the respective cot gene to ensure proper timing of expression during the sporulation process. Genetic stability was obtained by integrating the gene fusions into the B. subtilis chromosome in the coding sequence of the non-essential gene amyE (Cutting & Van der Horn, 1990 ).
The C terminus of CotB is formed of three 27 aa repeats that confer genetic instability on chimaeric proteins containing them (Isticato et al., 2004) . For this reason, for CotB fusions, the fragment of DNA coding for these three repeats was omitted leaving only part of this gene encoding the N-terminal 275 aa (Fig. 1) . For the CotBlinker fusion, we added the strong a-helix motif (GGGEAAAKGGG; Marqusee et al., 1989) between the C terminus of CotB and the N terminus of the FliD fragment by using appropriate sequence added to the primer for the distal part of cotB gene. When CotC, CotG or CotZ was used as carrier, DNA sequences encoding the entire Cot proteins were used (Fig. 1) .
As the heterologous part, we used a shorter form of FliD encompassing 86 aa (residues 226-311): N-TKSAVVYGK-NLEADVTDDQGRVTHISKEQNSFKIDNIDYNVNSKGS-AKLVSVTDTEEATKNMKAFVDDYNALMDKVYGLVTT-KKSK-C. This fragment of the fliD gene coding for putatively the most immunogenic regions was designated using the Antigen program (part of the EMBOSS package; http://emboss.sourceforge.net/).
The CotB-FliD fusion was obtained by cloning of the fliD gene fragment (258 bp) in frame with the serine codon at position 825 of cotB, the CotC-FliD fusion by cloning the fliD fragment in frame with the tyrosine codon at position 
Expression of C. difficile FliD on B. subtilis spores 198 of cotC, the CotG-FliD fusion by cloning the fliD fragment in frame with the lysine codon at position 585 of cotG, the CotZ-FliD fusion by cloning the fliD fragment in frame with the histidine codon at position 444 of cotZ, and the CotB-GGGEAAAKGGG-FliD fusion by cloning the fliD fragment in frame with the glycine codon at position 858 of the cotB-linker (Fig. 1 ).
All gene fusions were integrated into the B. subtilis chromosome and individual clones for each transformation were tested by PCR (not shown) and named BAN01 (CotB-FliD), BAN02 (CotC-FliD), BAN03 (CotG-FliD), BAN04 (CotZ-FliD) and BAN05 (CotB-GGGEAAAKGGGFliD) and used for further analysis.
The five recombinant strains and their isogenic parental strain 168 showed comparable sporulation and germination efficiencies, and their spores were equally resistant to chloroform and lysozyme treatment (not shown). Therefore, limited to the spore properties that we analysed, the presence of the Cot-FliD fusions did not affect spore structure or functionality.
Spore coat expression
To verify that the gene fusions were localized on the spore coat, we used a Western blot approach using anti-FliD antibodies against spore coat extracts from strain 168 and BAN01, BAN02, BAN03, BAN04 and BAN05 (Fig. 2) . We obtained a signal with extracts from spore coats of all recombinant strains. The recombinant proteins observed showed apparent molecular mass that correlated with the deduced molecular weights with the exception of the CotG fusion, which migrated as a 50 kDa protein instead of the deduced 36.6 kDa. This difference was caused by the electrophoretic properties of the CotG protein, because in purified form it migrates as a 36 kDa protein instead of the calculated 23.9 kDa (Sacco et al., 1995) . In addition, dimer formation of the CotZ protein may have caused the appearance of the two bands seen in Fig. 2 (lane 5).
Surface display
To analyse the surface exposure of Cot-fused FliD molecules, sporulating cells of wild-type and the isogenic recombinant strains were analysed by immunofluorescence microscopy with FliD-specific primary antibodies and Cy3-conjugated anti-mouse IgG as secondary antibody. We observed a fluorescent signal around purified dormant spores of all Cot-fused FliD spores but with different levels of fluorescence (Fig. 3) . Spores viewed by phase-contrast microscopy did not appear as bright white because of the plane of focus, which was set for optimal acquiring of the immunofluorescence signal.
For the CotB-FliD fusion, a weak fluorescent signal was observed around free, mature spores, a moderate fluorescence signal was observed for the fusions CotG-FliD, CotC-FliD and CotZ-FliD, and a strong signal was seen for the CotB-GGGEAAAKGGG-FliD fusion. These results indicated that all the Cot-fused FliD molecules were present on the spore coat surface and were available for antibody binding but with different efficiencies. 
Efficiency of expression
A quantitative determination of the amount of FliD present on the surface of B. subtilis spores was obtained by dot-blot experiments using serial dilutions of purified FliD and coat proteins extracted from spores of the wild-type and recombinant strains. The proteins were reacted with antiFliD antibody, followed by alkaline phosphatase-conjugated secondary antibodies and the colour was developed using nitroblue tetrazolium/5-bromo-4-chloro-3-indolylphosphate (BCIP/NBT; Bio-Rad). Densitometric analysis indicated that the CotB-FliD fusion protein amounted to 0.05 % of total coat proteins extracted, CotC-FliD to 0.11 %, CotG-FliD to 0.14 %, CotZ-FliD to 0.1 % and CotB-linker-FliD to 0.08 % (Table 3) . Considering the concentration of total spore protein in extracts obtained from each strain (4.7±0.21 mg ml -1 for BAN01, 4.6±0.19 mg ml 21 for BAN02, 5.1± 0.23 mg ml 21 for BAN03, 4.7±0.22 mg ml 21 for BAN04 and 5.0±0.25 mg ml 21 for BAN05), we calculated that the number of recombinant protein molecules extracted from each spore ranged between 6.9610 2 (BAN01) and 4.1610 3 (BAN03) ( Table 3) .
DISCUSSION
Recombinant B. subtilis spores have already been used as vehicles in oral vaccines (Duc et al., 2003; Mauriello et al., 2007; Permpoonpattana et al., 2011) and have proved to be very useful tools in such applications. The unique properties of the spore protective layers enable the efficient passage of delivered antigens under the harsh conditions of the stomach environment and additionally increase the attractiveness of the use of such spores in mucosal vaccines.
Following the suggestion proposed by Permpoonpattana et al. (2011) , an effective vaccine against C. difficile should be delivered mucosally. This suggestion supports observations by Péchiné et al. (2007) who tested three routes of mucosal delivery of C. difficile antigens -intranasal, rectal and intragastric -and showed decreased levels of colonization with these bacteria, especially in the case of rectal delivery.
The application of B. subtilis spores as vaccine vehicles was shown in the work of Permpoonpattana et al. (2011) who used B. subtilis spores displaying C-terminal repeat domains of toxins A and B of C. difficile as an oral vaccine and showed a protective effect in an animal model against infections with these bacteria.
It is worth pointing out that the presence of C. difficile toxins in the intestinal environment is probably connected with colonization or at least established infection during which bacteria could start to multiply. Therefore, it seems reasonable to use some of the surface antigens of C. difficile to design a vaccine that will enable earlier detection of infecting micro-organisms and increase the protective potential of the vaccine. Such a trial was undertaken by Péchiné et al. (2007) who successfully used the FliD protein for mucosal immunization.
In our work, we decided to follow the idea of surface antigen application in C. difficile vaccine design. We used a potentially immunogenic fragment of the FliD protein and successfully displayed it on the surface of B. Expression of C. difficile FliD on B. subtilis spores Isticato et al., 2001 Isticato et al., , 2007 Mauriello et al., 2004) , the use of CotZ was a new approach in this technology. The localization of CotZ in the crust suggested that the use of this protein as an anchor for heterologous protein should potentially increase spore surface exposition of such a chimaera. However, our results did not fully support this suggestion. The efficiency of surface display of recombinant FliD protein did not essentially differ between CotZ fusions and CotC and CotG fusions (Table 3) . According to the literature, CotC and CotG proteins are localized deeper in the spore coat structure than CotZ (McKenney & Eichenberger, 2012) and therefore CotC-and CotGanchored fusions should theoretically be displayed less efficiently on the spore surface compared with CotZ fusions. Nevertheless, the localization of fusion proteins in the spore coat structure depends most probably on both the passenger protein and the properties of the obtained fusion, and does not necessarily simply refer to the placement of the Cot protein in the spore coat structure.
Our data (Table 3) showed that the amount of recombinant FliD protein in the spore coat was highest when fused to CotG (4.1610 3 recombinant molecules per spore) and lowest for the CotB-based fusion (6.9610 2 recombinant molecules per spore). It is known from the literature that CotB-based fusions can show genetic instability (Isticato et al., 2004) ; therefore, to increase the efficiency of display of the CotB-FliD fusion, we decided to insert a strong ahelical peptide linker (GGGEAAAKGGG) in between these two fusion partners. This modification resulted in a significant increase in the amount of CotB-linker-FliD fusion protein in the spore coat (1.1610 3 recombinant molecules per spore). Taken together, our results suggest that, whilst the CotC, CotG and CotZ proteins seem to be good anchoring molecules for FliD, the use of CotB requires the addition of a linker to obtain comparable results expressed as the amount of recombinant FliD protein in the spore coat.
The recombinant spores of BAN02 (CotC-FliD), BAN03 (CotG-FliD), BAN04 (CotZ-FliD) and BAN05 (CotBlinker-FliD) seem to be good candidates for oral vaccine against C. difficile. Their usefulness should now be tested in immunizations of laboratory animals, as well as in challenge experiments. 
